Viewing Study NCT00188786



Ignite Creation Date: 2024-05-05 @ 11:57 AM
Last Modification Date: 2024-10-26 @ 9:17 AM
Study NCT ID: NCT00188786
Status: COMPLETED
Last Update Posted: 2011-02-15
First Post: 2005-09-12

Brief Title: Cone Beam CT for Daily Image Guidance - Prostate Cancer
Sponsor: University Health Network Toronto
Organization: University Health Network Toronto

Study Overview

Official Title: A Phase II Feasibility Study of Cone Beam Computed Tomography for Daily Image Guidance in Patients Receiving Dose Escalated Conformal Radiation Therapy for Prostate Cancer
Status: COMPLETED
Status Verified Date: 2011-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Conformal dose escalated radiation therapy CRT is standard treatment for patients with low and intermediate risk prostate cancer CRT requires accurate daily localization of the prostate prior to treatment to correct for prostate motion and set-up errors Cone beam computed tomography CT can accurately localize fiducial markers within the prostate Cone Beam CT also provides important information on daily position of organs within the pelvis This study aims to assess the feasibility of cone beam CT for daily localization of the prostate as well as document changes in size and location of pelvic organs during an entire course of CRT
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None